Evidence Library

Filter by drug, type, year, and open access.

Drug

Type

Year ≥

Sort

Open access

Active filters:Drug: valbenazine ×Clear filters

Showing 1–3 of 3 results

A long-term, open-label study of valbenazine for tardive dyskinesia — CNS Spectrums (2021)• Drug: valbenazineDOI
Tardive dyskinesia: placing vesicular monoamine transporter type 2 (VMAT2) inhibitors into clinical perspective — Expert Review of Neurotherapeutics (2018)• Drug: valbenazineDOI
KINECT 3: A phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia — American Journal of Psychiatry (2017)• Drug: valbenazineDOI

PsychMed Evidence Library — Guidelines, Trials, Meta-Analyses